Citadel Advisors - AMRYT PHARMA PLC ownership

AMRYT PHARMA PLC's ticker is AMYT and the CUSIP is 03217L106. A total of 67 filers reported holding AMRYT PHARMA PLC in Q1 2022. The put-call ratio across all filers is - and the average weighting 1.0%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of AMRYT PHARMA PLC
ValueSharesWeighting
Q4 2022$336,384
-25.2%
46,080
-29.2%
0.00%
Q3 2022$450,000
-48.9%
65,048
-48.3%
0.00%
Q2 2022$880,000
+76.0%
125,895
+108.1%
0.00%
Q1 2022$500,000
+5.3%
60,510
+37.7%
0.00%
Q4 2021$475,000
+236.9%
43,939
+278.1%
0.00%
Q3 2021$141,000
+4.4%
11,621
+4.4%
0.00%
Q2 2021$135,00011,1300.00%
Other shareholders
AMRYT PHARMA PLC shareholders Q1 2022
NameSharesValueWeighting ↓
Athyrium Capital Management, LP 8,857,268$61,912,00026.04%
Stonepine Capital Management, LLC 6,298,348$44,025,00020.48%
MPM ASSET MANAGEMENT LLC 2,668,843$18,655,0007.87%
Aquilo Capital Management, LLC 1,866,652$13,048,0004.45%
New Leaf Venture Partners, L.L.C. 449,737$3,144,0002.04%
Global Frontier Investments LLC 435,000$3,040,0001.42%
Rubric Capital Management LP 3,600,000$25,164,0001.32%
HIGHBRIDGE CAPITAL MANAGEMENT LLC 6,333,552$44,272,0001.01%
Telemetry Investments, L.L.C. 121,670$850,0001.01%
Clearline Capital LP 631,942$4,417,0000.57%
View complete list of AMRYT PHARMA PLC shareholders